Roche

in vitro method for producing large amounts of specific DNA or RNA fragments from small amounts of short oligonucleotide primers

thumb|Participation certificate of the F. Hoffmann-LaRoche & Co AG, issued 15 January 1932

Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It operates as an independent subsidiary of holding company Roche. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.

Switzerland company in Japan

skyscraper in Basel

Emicizumab, sold under the brand name Hemlibra, is a humanized bispecific monoclonal antibody for the treatment of haemophilia A, developed by Genentech and Chugai (both organizations are subsidiaries of Hoffmann-La Roche). Emicizumab is a bispecific factor IXa- and factor X-directed antibody.

skyscraper in Basel

American genomics company